237 related articles for article (PubMed ID: 15891884)
1. Development of a whole cell vaccine for acute myeloid leukaemia.
Cheuk AT; Chan L; Czepulkowski B; Berger SA; Yagita H; Okumura K; Farzaneh F; Mufti GJ; Guinn BA
Cancer Immunol Immunother; 2006 Jan; 55(1):68-75. PubMed ID: 15891884
[TBL] [Abstract][Full Text] [Related]
2. Immunotherapy of acute myeloid leukaemia: development of a whole cell vaccine.
Cheuk AT; Guinn BA
Front Biosci; 2008 Jan; 13():2022-9. PubMed ID: 17981688
[TBL] [Abstract][Full Text] [Related]
3. An immune edited tumour versus a tumour edited immune system: Prospects for immune therapy of acute myeloid leukaemia.
Chan L; Hardwick NR; Guinn BA; Darling D; Gäken J; Galea-Lauri J; Ho AY; Mufti GJ; Farzaneh F
Cancer Immunol Immunother; 2006 Aug; 55(8):1017-24. PubMed ID: 16450142
[TBL] [Abstract][Full Text] [Related]
4. [Immunotherapy of acute myeloid leukemias: development of vaccines and cell therapy approaches].
Mohty M; Gaugler B; Calmels B; Blaise D; Vey N; Chabannon C; Olive D
Bull Cancer; 2003; 90(8-9):751-7. PubMed ID: 14609765
[TBL] [Abstract][Full Text] [Related]
5. Gene immunotherapy in murine acute myeloid leukemia: granulocyte-macrophage colony-stimulating factor tumor cell vaccines elicit more potent antitumor immunity compared with B7 family and other cytokine vaccines.
Dunussi-Joannopoulos K; Dranoff G; Weinstein HJ; Ferrara JL; Bierer BE; Croop JM
Blood; 1998 Jan; 91(1):222-30. PubMed ID: 9414288
[TBL] [Abstract][Full Text] [Related]
6. Microarray analysis of tumour antigen expression in presentation acute myeloid leukaemia.
Guinn BA; Gilkes AF; Woodward E; Westwood NB; Mufti GJ; Linch D; Burnett AK; Mills KI
Biochem Biophys Res Commun; 2005 Aug; 333(3):703-13. PubMed ID: 15963951
[TBL] [Abstract][Full Text] [Related]
7. Immunotherapy of elderly acute myeloid leukemia: light at the end of a long tunnel?
Rafelson WM; Reagan JL; Fast LD; Lim SH
Leuk Lymphoma; 2017 Nov; 58(11):2523-2531. PubMed ID: 28351186
[TBL] [Abstract][Full Text] [Related]
8. A systematic overview of chemotherapy effects in acute myeloid leukaemia.
Kimby E; Nygren P; Glimelius B;
Acta Oncol; 2001; 40(2-3):231-52. PubMed ID: 11441935
[TBL] [Abstract][Full Text] [Related]
9. Immunotherapy of myeloid leukaemia.
Guinn BA; Mohamedali A; Thomas NS; Mills KI
Cancer Immunol Immunother; 2007 Jul; 56(7):943-57. PubMed ID: 17180671
[TBL] [Abstract][Full Text] [Related]
10. Impaired antigen presentation in neoplasia: basic mechanisms and implications for acute myeloid leukemia.
van Luijn MM; van den Ancker W; Chamuleau ME; Ossenkoppele GJ; van Ham SM; van de Loosdrecht AA
Immunotherapy; 2010 Jan; 2(1):85-97. PubMed ID: 20635891
[TBL] [Abstract][Full Text] [Related]
11. Immunotherapy of acute myeloid leukemia: current approaches.
Smits EL; Berneman ZN; Van Tendeloo VF
Oncologist; 2009 Mar; 14(3):240-52. PubMed ID: 19289488
[TBL] [Abstract][Full Text] [Related]
12. Feasibility of clinical dendritic cell vaccination in acute myeloid leukemia.
Houtenbos I; Westers TM; Ossenkoppele GJ; van de Loosdrecht AA
Immunobiology; 2006; 211(6-8):677-85. PubMed ID: 16920506
[TBL] [Abstract][Full Text] [Related]
13. Dendritic cell-based immunotherapy in myeloid leukaemia: translating fundamental mechanisms into clinical applications.
van de Loosdrecht AA; van den Ancker W; Houtenbos I; Ossenkoppele GJ; Westers TM
Handb Exp Pharmacol; 2009; (188):319-48. PubMed ID: 19031033
[TBL] [Abstract][Full Text] [Related]
14. Immunological weapons against acute myeloid leukaemia.
Galea-Lauri J
Immunology; 2002 Sep; 107(1):20-7. PubMed ID: 12225359
[TBL] [Abstract][Full Text] [Related]
15. Immunotherapy in leukaemia.
Van De Velde AL; Anguille S; Berneman ZN
Acta Clin Belg; 2012; 67(6):399-402. PubMed ID: 23340144
[TBL] [Abstract][Full Text] [Related]
16. Rapid generation of antigen-presenting cells from leukaemic blasts in acute myeloid leukaemia.
Westers TM; Stam AG; Scheper RJ; Regelink JC; Nieuwint AW; Schuurhuis GJ; van de Loosdrecht AA; Ossenkoppele GJ
Cancer Immunol Immunother; 2003 Jan; 52(1):17-27. PubMed ID: 12536236
[TBL] [Abstract][Full Text] [Related]
17. Immunotherapy for Acute Myeloid Leukemia: Allogeneic hematopoietic cell transplantation is here to stay.
Kaleka G; Schiller G
Leuk Res; 2022 Jan; 112():106732. PubMed ID: 34864447
[TBL] [Abstract][Full Text] [Related]
18. Immunotherapy with acute leukemia cells modified into antigen-presenting cells: ex vivo culture and gene transfer methods.
Stripecke R; Levine AM; Pullarkat V; Cardoso AA
Leukemia; 2002 Oct; 16(10):1974-83. PubMed ID: 12357348
[TBL] [Abstract][Full Text] [Related]
19. Dendritic cell-based immunotherapy in acute and chronic myeloid leukaemia.
Westers TM; Ossenkoppele GJ; van de Loosdrecht AA
Biomed Pharmacother; 2007 Jul; 61(6):306-14. PubMed ID: 17368821
[TBL] [Abstract][Full Text] [Related]
20. Randomised comparison of addition of autologous bone-marrow transplantation to intensive chemotherapy for acute myeloid leukaemia in first remission: results of MRC AML 10 trial. UK Medical Research Council Adult and Children's Leukaemia Working Parties.
Burnett AK; Goldstone AH; Stevens RM; Hann IM; Rees JK; Gray RG; Wheatley K
Lancet; 1998 Mar; 351(9104):700-8. PubMed ID: 9504514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]